SPDR S&P Biotech ETF Sees Unusually High Options Volume (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) saw some unusual options trading on Tuesday. Traders bought 75,452 put options on the stock. This is an increase of 51% compared to the typical volume of 50,080 put options.

SPDR S&P Biotech ETF Trading Up 0.3%

Shares of SPDR S&P Biotech ETF stock opened at $115.18 on Wednesday. The stock has a market capitalization of $6.99 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $116.18. The business’s 50 day simple moving average is $105.00 and its 200-day simple moving average is $92.05.

Institutional Investors Weigh In On SPDR S&P Biotech ETF

Several large investors have recently added to or reduced their stakes in the stock. Cerity Partners LLC lifted its position in SPDR S&P Biotech ETF by 5.8% in the 1st quarter. Cerity Partners LLC now owns 18,605 shares of the exchange traded fund’s stock valued at $1,509,000 after purchasing an additional 1,016 shares during the last quarter. CWM LLC increased its stake in shares of SPDR S&P Biotech ETF by 27.7% in the first quarter. CWM LLC now owns 16,673 shares of the exchange traded fund’s stock valued at $1,352,000 after purchasing an additional 3,616 shares during the period. Bank Julius Baer & Co. Ltd Zurich increased its stake in shares of SPDR S&P Biotech ETF by 5.5% in the first quarter. Bank Julius Baer & Co. Ltd Zurich now owns 13,876 shares of the exchange traded fund’s stock valued at $1,125,000 after purchasing an additional 722 shares during the period. Proficio Capital Partners LLC raised its holdings in shares of SPDR S&P Biotech ETF by 63.6% during the first quarter. Proficio Capital Partners LLC now owns 17,783 shares of the exchange traded fund’s stock valued at $1,440,000 after buying an additional 6,915 shares during the last quarter. Finally, Garrison Bradford & Associates Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the first quarter worth approximately $39,000.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.